News

Pfizer (NYSE: PFE) is a company that's in the midst of a transition. The COVID-19 vaccine maker benefited from a huge revenue boost due to the pandemic. Now, however, as the government is no longer

Shares of CureVac (NASDAQ: CVAC) were down 9.1% as of 2:45 p.m. ET Thursday after a German court temporarily suspended the biopharmaceutical company's patent trial against BioNTech (NASDAQ: BNTX).

The field of Alzheimer's disease (AD) has been where experimental drugs come to die in the past couple of decades. Many companies have tried and largely failed to develop new and effective therapies

AT&T (NYSE: T) is one of the oldest and largest telecom companies in the U.S., with roots going back to 1876. These days, however, the stock has been synonymous with underwhelming returns and plenty

Dividend stocks can be excellent sources of recurring income. But you'll inevitably need money to make a decent amount from dividends. If you can afford to invest $70,000, then you could earn more

40, 36, 1.

Space is hard, as the saying goes. Since its very first rocket launch from Launch Complex 1 in New Zealand, small rocket company Rocket Lab USA (NASDAQ: RKLB) has attempted 40 separate

Shares of Apellis Pharmaceuticals (NASDAQ: APLS) were down more than 9% on Wednesday, after falling as much as 12% earlier in the day. The company's shares fell following a short-seller report on

Ginkgo Bioworks (NYSE: DNA) is having a strong showing today. Specifically, the synthetic biology company's shares were up by 10.1% on heavy volume as of 9:57 a.m. ET Wednesday morning.

What's

When a company that's increased its dividend annually since its initial public offering announces that it's planning to cut the payment, you know something big is going on. That's exactly what's

Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) are seeing explosive gains in Tuesday's trading following an announcement that the company is on track to be acquired by Alfasigma, a private

Fool.com contributor Parkev Tatevosian measures AT&T (NYSE: T) across vital financial metrics that help determine dividend sustainability.

*Stock prices used were the afternoon prices of Sept. 21

Building positions in dividend stocks can help investors overcome market volatility and generate reliable passive income streams.

If you're looking to add dependable, income-generating stocks to

Growth: It's what every investor would like to have from the stocks they buy. That's true even for individuals who are primarily seeking income.

Three Fool.com contributors believe they've

Intellia Therapeutics (NASDAQ: NTLA) and Rocket Pharmaceuticals (NASDAQ: RCKT) are gene-editing biotechs that want to offer what few others can: cures for hereditary afflictions that have so far

Abbott Laboratories (NYSE: ABT) is seen as a solid safe-harbor stock because of the company's 135-year history, its diversified healthcare business, and its reliable dividend.

The company is known

Pharmaceutical giant Merck (NYSE: MRK) has delivered excellent returns to its shareholders over the past 12 months, as last year's downturn did little to slow the drugmaker. The company's solid